Developing a gene therapy platform based on DNA-directed RNA interference.
Industry: Health Care
First Day Return: -13.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 06/22/2015 |
Offer Price | $9.21 |
Price Range $10.00 - $10.00 | |
Offer Shares (mm) | 1.5 |
Deal Size ($mm) | $14 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 08/18/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $14 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Balmain, Australia |
Founded | 1995 |
Employees at IPO | 21 |
Website www.benitec.com |